Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.

Calle EE, Feigelson HS, Hildebrand JS, Teras LR, Thun MJ, Rodriguez C.

Cancer. 2009 Mar 1;115(5):936-45. doi: 10.1002/cncr.24101. Erratum in: Cancer. 2009 Apr 1;115(7):1587.

2.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

PMID:
16150813
3.

Hormone therapy and breast cancer risk.

Foidart JM, Desreux J, Pintiaux A, Gompel A.

Climacteric. 2007 Oct;10 Suppl 2:54-61. Review.

PMID:
17882674
4.
5.
6.

Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.

Biglia N, Mariani L, Sgro L, Mininanni P, Moggio G, Sismondi P.

Endocr Relat Cancer. 2007 Sep;14(3):549-67. Review.

7.

Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.

Vogel VG.

Menopause. 2008 Jul-Aug;15(4 Suppl):782-9. doi: 10.1097/gme.0b013e3181788d88. Review.

PMID:
18596599
8.

Effect of endogenous and exogenous hormones on breast cancer: epidemiology.

Vessey MP.

Verh Dtsch Ges Pathol. 1997;81:493-501. Review.

PMID:
9474890
9.

Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.

Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR.

Gynecol Endocrinol. 2009 Dec;25(12):807-15. doi: 10.3109/09513590903056878. Review.

PMID:
19906000
10.

Postmenopausal hormone therapy and breast cancer.

Speroff L.

Obstet Gynecol. 1996 Feb;87(2 Suppl):44S-54S. Review.

PMID:
8559553
11.

Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.

Ravdin PM.

Breast Dis. 2008-2009;30:3-8. doi: 10.3233/BD-2009-0283. Review.

PMID:
19850989
12.

Estrogen, estrogen plus progestin therapy, and risk of breast cancer.

Colditz GA.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s. Review.

13.

Health consequences of short- and long-term postmenopausal hormone therapy.

Weiss NS.

Clin Chem. 1996 Aug;42(8 Pt 2):1342-4. Review.

14.

Progestogen use in women approaching the menopause and breast cancer risk.

Campagnoli C, Ambroggio S, Lotano MR, Peris C.

Maturitas. 2009 Apr 20;62(4):338-42. doi: 10.1016/j.maturitas.2008.10.017. Epub 2008 Dec 31. Review.

PMID:
19118958
15.

Breast cancer and hormone replacement therapy: putting the risk into perspective.

Campagnoli C, AbbĂ  C, Ambroggio S, Biglia N, Ponzone R.

Gynecol Endocrinol. 2001 Dec;15 Suppl 6:53-60. Review.

PMID:
12227887
16.

[Review of risk factors for breast cancer--what's new?].

Haimov-Kochman R, Lavy Y, Hochner-Celinkier D.

Harefuah. 2002 Aug;141(8):702-8, 761. Review. Hebrew.

PMID:
12222134
17.

Breast cancer risk and hormone replacement therapy: a review of the epidemiology.

Hunt K.

Int J Fertil Menopausal Stud. 1994;39 Suppl 2:67-74. Review.

PMID:
7874189
18.

Hormone replacement therapy and breast cancer risk.

Gambrell RD Jr.

Arch Fam Med. 1996 Jun;5(6):341-8. Review.

PMID:
8640324
19.

Steroid hormones and risk of breast cancer.

Hulka BS, Liu ET, Lininger RA.

Cancer. 1994 Aug 1;74(3 Suppl):1111-24. Review.

20.

Hormones and breast cancer.

Helzlsouer KJ, Couzi R.

Cancer. 1995 Nov 15;76(10 Suppl):2059-63. Review.

Supplemental Content

Support Center